References
1. Guillevin L, Le Thi Huong D, Godeau P, et al. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol 1988;27:258–264.
2. Lhote F, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome: clinical aspects and treatment. Rheum Dis North Am 1995;21:911–947.
3. Kart-Koseoglou H, Yucel AE, Aytekin C, et al. Polyarteritis nodosa complicated by intrahepatic-perihepatic hemorrhage and acute appendicitis: successful treatment with cyclophosphamide and corticosteroids. Clin Rheumatol 2003;22:251–253.
4. Dauphine C, Kovar J, de Virqilio C. Successful nonoperative management of acute intraperitoneal hemorrhage due to undiagnosed polyarteritis nodosa. Ann Vasc Surg 2005;19:724–727.
5. Guillevin L, Lhote F, Cohen P, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation in 41 patients. Medicine (Baltimore) 1995;74:238–253.
6. Ramos Casals M, Jara LJ, Medina F, et al. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med 2005;257:549–557.
7. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354:54–66.
8. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929–938.
9. Lightfoot RW Jr, Michael BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088–1093.
10. Levine SM, Hellmann DB, Stone JH. Gastrointestinal involvement in polyarteritis nodosa (1986–2000): presentation and outcomes in 24 patients. Am J Med 2002;112:386–391.
11. Ruiz-Irastorza G, Egurbide MV, Aguirre C. Polyarteritis nodosa presenting as ischaemic colitis. Br J Rheumatol 1996;35:1333–1334.
12. Hervé F, Héron F, Levesque H, et al. Ascites as the first manifestation of polyarteritis nodosa. Scand J Gastroenterol 2006;41:493–495.
13. Cjaza AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984;4:1–12.
14. Lee WJ, Kim CH, Chang SE, et al. A case of cutaneous polyarteritis nodosa in autoimmune hepatitis. Acta Derm Venereol 2009;89:442–443.
15. Inada C, Yoshida H, Sumino M, et al. A case of microscopic polyarteritis nodosa associated with autoimmune hepatitis complicated with rheumatoid arthritis and chronic thyroiditis. Nippon Shokakibyo Gakkai Zasshi 2000;97:925–929.
16. Mowrey FH, Lundberg EA. The clinical manifestations of essential polyangiitis (periarteritis nodosa), with emphasis on the hepatic manifestations. Ann Intern Med 1954;40:1145–1164.
17. Parangi S, Oz MC, Blume RS, et al. Hepatobiliary complications of polyarteritis nodosa. Arch Surg 1991;126:909–912.
18. Dutta U, Rana SS, Lal A, et al. Hemobilia as presenting manifestation of polyarteritis nodosa. Indian J Gastroenterol 2004;23:71–72.
19. Goritsas CP, Repanti M, Papadaki E, et al. Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa. J Hepatol 1997;26:727–730.
20. Matsumoto T, Kobayashi S, Shimizu H, et al. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000;20:366–373.